The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity

Nasopharyngeal carcinoma (NPC) is a malignant tumor with poor prognosis, high morbidity, and mortality. Currently, immunocheckpoint therapy has led to new treatment strategies for almost all cancers, including nasopharyngeal carcinoma. Inducible T-cell aggregation ligand (ICOSL) belongs to the b7-cd...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Geng, Xu, Yi, Zhang, Sen, Zhou, Huifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973197/
https://www.ncbi.nlm.nih.gov/pubmed/31998801
http://dx.doi.org/10.1155/2020/9756732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973197/
https://www.ncbi.nlm.nih.gov/pubmed/31998801
http://dx.doi.org/10.1155/2020/9756732

Ejemplares similares